DFTX · Company research
Definium Therapeutics, Inc. Common Shares (DFTX): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
16records availableBasic Materials
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| DFTX Vs CMPS: Which Stock Has More Upside From Trump’s New Psychedelic Therapy Push? - Stocktwits | DFTX Vs CMPS: Which Stock Has More Upside From Trump’s New Psychedelic Therapy Push? Stocktwits | View source ↗ | Stocktwits | Oct 16, 2026 | neutral | 0 | 0.6 |
| DFTX Jan 2027 33.000 put (DFTX270115P00033000) Interactive Stock Chart - Yahoo Finance - Yahoo! Finance Canada | DFTX Jan 2027 33.000 put (DFTX270115P00033000) Interactive Stock Chart - Yahoo Finance Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 16, 2026 | neutral | 0 | 0.6 |
| Two new hires receive options to buy 45,940 Definium shares - Stock Titan | Two new hires receive options to buy 45,940 Definium shares Stock Titan | View source ↗ | Stock Titan | Oct 13, 2026 | neutral | 0 | 0.6 |
| Definium Therapeutics (NasdaqGS:DFTX) Stock Forecast & Analyst Predictions - Simply Wall Street | Definium Therapeutics (NasdaqGS:DFTX) Stock Forecast & Analyst Predictions Simply Wall Street | View source ↗ | Simply Wall Street | Oct 13, 2026 | neutral | 0 | 0.6 |
| DFTX Initiated Coverage By JP Morgan -- Rating Set To Overweight - GuruFocus | DFTX Initiated Coverage By JP Morgan -- Rating Set To Overweight GuruFocus | View source ↗ | GuruFocus | Oct 9, 2026 | neutral | 0 | 0.6 |
| DFTX Stock Rallies As Psychedelic Drug Delivers Positive Anxiety Trial Results — Retail Says DT120 Could ‘Disrupt The Market’ - Stocktwits | DFTX Stock Rallies As Psychedelic Drug Delivers Positive Anxiety Trial Results — Retail Says DT120 Could ‘Disrupt The Market’ Stocktwits | View source ↗ | Stocktwits | Oct 8, 2026 | neutral | 0 | 0.6 |
| The Technical Signals Behind (DFTX) That Institutions Follow - Stock Traders Daily | The Technical Signals Behind (DFTX) That Institutions Follow Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 7, 2026 | neutral | 0 | 0.6 |
| Definium Therapeutics (DFTX) Stock Climbed, So What Is Behind The Fresh Attention? - Simply Wall Street | Definium Therapeutics (DFTX) Stock Climbed, So What Is Behind The Fresh Attention? Simply Wall Street | View source ↗ | Simply Wall Street | Sep 28, 2026 | neutral | 0 | 0.6 |
| 15 new hires get the right to buy Definium shares in stages over four years - Stock Titan | 15 new hires get the right to buy Definium shares in stages over four years Stock Titan | View source ↗ | Stock Titan | Sep 28, 2026 | neutral | 0 | 0.6 |
| DFTX Stock Jumps Overnight As Investors Brace For Phase 3 Results From LSD-Based Anxiety Drug - Stocktwits | DFTX Stock Jumps Overnight As Investors Brace For Phase 3 Results From LSD-Based Anxiety Drug Stocktwits | View source ↗ | Stocktwits | Sep 13, 2026 | neutral | 0 | 0.6 |
| Definium Therapeutics Stock (DFTX) Opinions on Analyst Upgrade and Regulatory Progress - Moomoo | Definium Therapeutics Stock (DFTX) Opinions on Analyst Upgrade and Regulatory Progress Moomoo | View source ↗ | Moomoo | Sep 4, 2026 | neutral | 0 | 0.6 |
| $DFTX stock is down 4% today. Here's what we see in our data. - Quiver Quantitative | $DFTX stock is down 4% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 28, 2026 | neutral | 0 | 0.6 |
| Definium will discuss Phase 3 anxiety-drug results at September events - Stock Titan | Definium will discuss Phase 3 anxiety-drug results at September events Stock Titan | View source ↗ | Stock Titan | Aug 26, 2026 | neutral | 0 | 0.6 |
| How Investors May Respond To Definium Therapeutics (DFTX) Phase 3 Anxiety Trial Success With DT120 ODT - Webull | How Investors May Respond To Definium Therapeutics (DFTX) Phase 3 Anxiety Trial Success With DT120 ODT Webull | View source ↗ | Webull | Aug 25, 2026 | neutral | 0 | 0.6 |
| DFTX Stock On Track For Worst Day In 9 Months As Investors Brace For Anxiety Trial Data - Yahoo Finance | DFTX Stock On Track For Worst Day In 9 Months As Investors Brace For Anxiety Trial Data Yahoo Finance | View source ↗ | Yahoo Finance | Aug 11, 2026 | neutral | 0 | 0.6 |
| Is Definium Therapeutics, Inc. (DFTX) Stock Poised for Further Gains After Positive Emerge Trial Update? - Yahoo Finance | Is Definium Therapeutics, Inc. (DFTX) Stock Poised for Further Gains After Positive Emerge Trial Update? Yahoo Finance | View source ↗ | Yahoo Finance | Jun 30, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.